It is found that a new type of artificial antibiotic can successfully resist the infection of superbacteria

It is estimated that 10 million people will be infected by drug-resistant bacteria every year by 2050, so it is very important to develop new antibiotics In a recent study published in the Journal of medical chemistry, a new artificial antibiotic can successfully resist the infection of superbugs This breakthrough is also of great significance for the development of new drugs like teixostatin (http:// Researchers from the University of Lincoln in the UK found a synthetic drug similar to terpastein (http:// that can treat bacterial infections in mice This discovery shows that the new compound can be used as a template for the development of new antibiotics By replacing the amino acids in the key parts of the antibiotic structure, the researchers made the preparation process of the drug easier In addition, this simplified version of the drug-resistant bacteria has a strong ability to kill in vitro After that, researchers from the Singapore Institute of Ophthalmology examined (http:// the therapeutic effect of the compound on mouse infection The results show that the drug can not only eliminate infection, but also minimize the negative symptoms of infection, which is far better than the commonly used antibiotic moxifloxacin.